
Tata Elxsi has announced the launch of a dedicated offshore development centre for Terumo Corporation, marking a significant step in its healthcare technology initiatives. The new centre is designed to support the development of advanced medical solutions and strengthen collaboration between the two companies across global markets.
The newly established “Terumo–Tata Elxsi Offshore Development Center” will focus on supporting the development of cardiac and vascular technologies. Located in Pune, the centre will serve as a hub for engineering and innovation, enabling continuous support across product lifecycles in international markets.
The initiative brings together specialised teams working across design, engineering, and digital capabilities to accelerate product development and improve responsiveness to evolving healthcare requirements. It reflects a long-term collaboration aimed at enhancing Terumo’s product pipeline and expanding its technological capabilities.
The centre integrates a broad range of capabilities including product design, verification, and localisation, supported by advanced digital technologies. Tata Elxsi is leveraging artificial intelligence and generative AI to streamline development processes and enable faster innovation cycles.
This approach is expected to help deliver patient-focused medical devices with improved efficiency and differentiation. By combining engineering expertise with digital tools, the centre aims to enhance performance and reliability in cardiac and vascular solutions while enabling quicker adaptation to regional market needs.
The collaboration is positioned to support the growing demand for advanced medical technologies globally. By aligning Tata Elxsi’s multidisciplinary expertise with Terumo’s domain focus, the partnership is expected to contribute to the development of next-generation healthcare solutions.
The centre is also expected to improve operational efficiency, reduce development timelines, and strengthen the ability to scale innovations across multiple geographies.
As of 20 March 2026, at 9:23 AM, Tata Elxsi Ltd share price is trading at ₹4,143.70 per share, reflecting a gain of 2.58% from the previous closing price. Over the past month, the stock has declined by 14.72%.
The launch of the offshore development centre underscores Tata Elxsi’s focus on expanding its role in healthcare technology, while reinforcing its partnership with Terumo to drive innovation in critical medical segments.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 20, 2026, 11:07 AM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
